UPDATE: (Nov. 16, 2016) – The American Heart Association has announced that PPI use is related to an increased risk of ischemic stroke. This is in addition to the 96% increased risk of acute kidney failure from taking PPI’s.
Ischemic strokes are the most common type of stroke and occur when a blood clot cuts off blood flow to the brain. The overall stroke risk increased 21% among patients who were taking a PPI, but the risk is higher for certain PPI’s compared to others:
• Pantoprazole: Protonix (79% increased risk for stroke)
• Esomeprazole: Nexium (50% increased risk for stroke)
• Omeprazole: Prilosec (33% increased risk for stroke)
• Lansoprazole: Prevacid (33% increased risk for stroke)
If you or a loved one have taken Protonix, Nexium, Prilosec, or Prevacid and been diagnosed or hospitalized with an ischemic stroke, contact us online or call 1-866-252-3535 for a free consultation.
Popular prescription heartburn drugs known as “Protein Pump Inhibitors” (PPIs) have recently been linked to an increased risk of acute kidney failure (acute interstitial nephritis); the risk of developing ‘acute interstitial nephritis’ was 96% higher for people taking PPIs, and decline in kidney function was 32% higher for people taking PPIs. According to researchers, acute interstitial nephritis can appear as early as 120 days of initiating a regular regimen of one of these drugs. Both medical studies, published in 2016, appear to be of high scientific quality, thus proving the dangers of these drugs.
These PPI’s are not only used to treat heartburn, but also GERD (gastroesophageal reflux disease), duodenal ulcer disease, and erosive esophagitis. The specific drugs at issue are:
• Omeprazole: Prilosec
• Lansoprazole: Prevacid
• Esomeprazole: Nexium
• Rabeprazole: Aciphex
• Pantoprazole: Protonix
Approximately 15 million people in the US alone are taking either over-the-counter or prescription PPI medications. In 2013, Nexium was the second-best selling drug in the pharmaceutical industry, generating over $6.1 billion in sales worldwide for AstraZeneca, as reported by Medscape. There are several alternative drugs that are available which are safer and do not carry the same risks, such as Zantac, Pepcid, and Tagamet. Even though Zantac, Pepcid, and Tagamet are not associated with the same kidney risks as PPIs, their sales have plummeted since Prilosec, Nexium and other PPIs were introduced and aggressively marketed by AstraZeneca, Pfizer and other PPI manufacturers.
If you or a loved one have taken Prilosec, Prevacid, Protonix, Aciphex, or Nexium and been diagnosed or hospitalized with ‘acute interstitial nephritis’ contact us online or call 1-866-252-3535 for a free consultation.